Talzenna .75 mg/1 (Talazoparib CAPSULE, LIQUID FILLED) .75 mg/1

Talzenna .75 mg/1 is a medication containing talazoparib, used for targeted therapy. This liquid-filled capsule is designed for oral administration and comes in a 30-count bottle.

Strength

.75 mg/1

Pack Size

30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0655-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna .75 mg/1 is primarily used in the treatment of certain types of cancer. Talazoparib is a PARP inhibitor, which works by targeting specific enzymes involved in DNA repair. This medication is often prescribed for patients with specific genetic mutations that affect DNA repair mechanisms. What is Talzenna used for? It is typically used in the management of advanced or metastatic breast cancer with specific genetic markers.

Side Effects

Common effects of Talzenna .75 mg/1 may include fatigue, nausea, and anemia. Some users might experience vomiting, decreased appetite, and hair loss. These effects can vary in intensity and duration among individuals. It is important to monitor for any adverse reactions and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

Talzenna .75 mg/1 should be handled with care and stored as directed. It is crucial to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Talzenna .75 mg/1 may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided as it may exacerbate side effects. It is important to discuss all current medications, including over-the-counter drugs and supplements, with your healthcare provider to ensure safe use.

Frequently Asked Questions

Talzenna is used in the treatment of certain types of cancer, particularly those with specific genetic mutations affecting DNA repair mechanisms.

Talzenna .75 mg/1 is administered orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, anemia, vomiting, decreased appetite, and hair loss.

Talzenna may interact with other medications, so it is important to discuss all current medications with your healthcare provider.

Pregnant women or those planning to become pregnant should consult their healthcare provider about the potential risks of taking Talzenna.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.